原发性肺动脉高压病因与发病机制研究进展
被引量：2
摘要
原发性肺动脉高压预后险恶 ,现有治疗药物和治疗手段无法改变其自然病程和预后 ,因而病因与发病机制研究一直是该领域的热点和难点。本文将从组织病理、细胞学、相关介质以及遗传学方面对PPH病因和发病机制的研究现状进行简要综述。
出处
《国外医学（内科学分册）》
2001年第1期4-7,12,共5页
Foreign Medical Sciences(Section of Internal Medicine)
参考文献18
-
1[1]Pietra GC, Edwards WD, Kay JM, et al. [ J]. Circulation, 1989,80:1198-1206.
-
2[2]Giaid A, Yanagisawa M, Langleben D, et al. [J]. N Engl J Med, 1993,328:1732-1739.
-
3[3]Moser KM, Fedullo PF, Finkbeiner WE, et al. [J].Circulation, 1995,91:741-745.
-
4[4]Farber HW, Loscalzo J. [J]. J Lab Clin Med, 1999,134(6) :561-566.
-
5[5]Afred P. [J]. Chest, 1998,114:242s-247s.
-
6[6]Robyn J, Bars T, James E, et al. [J]. Chest, 1998,114: 231 s-236s.
-
7[7]Tuder RM, Groves B, Badesch DB, et al. [ J]. Am J Pathol, 1994,144:275-285.
-
8[8]Lee SD, Shroyer KR, Markham NE, et al. [J]. J Clin Invest, 1998,101:927-934.
-
9[9]Yuan XJ,Aldinger A,Orens J,et al. [J]. Circulation,1996,94:1-49.
-
10[10]Weir EK, Helen L, Gerhard J, et al. [J]. Chest, 1998,114: 200s-204s.
同被引文献12
-
1杨媛华,王辰.肺动脉高压的发病机制及治疗进展[J].国外医学（呼吸系统分册）,2004,24(5):323-325. 被引量：12
-
2郭淑静,闫琦,丁春华.原发性肺动脉高压的诊治进展[J].国外医学（呼吸系统分册）,2005,25(10):767-769. 被引量：5
-
3Law MA, Grifka RG, Mullins CE, et al. Atrial septostomy improves survival in select patients with pulmonary hypertension. Am Heart J, 2007, 153(5) :779-784.
-
4Mahapatra S, Nishimura RA, Oh JK, et al. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr, 2006, 19 (8) : 1045- 1050.
-
5Grifoni S, Vanni S, Magazzini S, et al. Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events. Arch Intern Med, 2006, 166(19) :2151-2156.
-
6Sakamaki F, Kyotani S, Nagaya N, et al. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation, 2000, 102 (22) :2720-2725.
-
7Hoeper MM, Schwarze M, Ehlerding S, et al. Long-term treatment of primary pulmonary hypertension with aerosolized ilo-prost, a prostacyclin analogue. N Engl J Med, 2000, 342(24) : 1866-1870.
-
8Yadav R, Anandaraja S, Bhargava B, et al. Acute hemodynamic effects of nicorandil in patients with primary pulmonary arterial hypertension. Indian Heart J, 2005,57 (6) :666-669.
-
9Sayin T, Ozenci M. Sustained long-term benefit of sildenafil in primary pulmonary hypertension. Acta Cardiol, 2007, 62 ( 1 ) :47-49.
-
10Saji K, Sakuma M, Suzuki J, et al. Efficacy of acute inhalation of nitric oxide in patients with primary pulmoary hypertension using chronic use of continuous epoprostenol infusion. Circ J, 2005, 69(3) :335-338.
-
1李志晋.炎症性肠病病因与发病机制的研究进展[J].胃肠病学和肝病学杂志,2002,11(2):183-185. 被引量：5
-
2李文彪,刘星,张蕴慧.高脂血症病因与发病[J].山东中医药大学学报,1999,23(5):336-337. 被引量：14
-
3周焕明,陈辉.消化性溃疡治疗的合理用药[J].中国全科医学,2001,4(8):653-654. 被引量：3
-
4李国强,张玉华,魏路清.特发性肺纤维化急性加重的诊断及治疗[J].山东医药,2008,48(46):113-114.
-
5张爱民,张桂芬,柴小红.TF和P-选择素检测在慢性阻塞性肺疾病急性加重期中的临床意义[J].临床肺科杂志,2015,20(3):523-525. 被引量：3
-
6熊江英.丹红注射液辅助治疗肺心病呼吸衰竭疗效观察[J].中国实用医药,2011,6(24):149-150.
-
7Feld J.J.,Dinh H.,Arenovich T.,李翔.自身免疫性肝炎:症状及肝硬化对自然病程和预后的影响[J].世界核心医学期刊文摘（胃肠病学分册）,2005,0(10):38-39. 被引量：7
-
8子布,张昭（摘）.脂肪肝和脂肪性肝病是一回事吗[J].健康文摘,2008(7):43-43.
-
9吴东海.药物的4种选择[J].家庭医药（就医选药）,2004(1):41-41.
-
10黄颐,孙学礼,付华.心血管疾病中的心理问题[J].国外医学（精神病学分册）,2004,31(1):10-12. 被引量：30
